You can zoom in on the map to see where we work in your region, and select a country to find out more.
We focus on access to affordable medicines in middle-income countries (MICs). Less than a third of the people in need of HIV treatment in MICs are currently able to access it, and it is a similar story when it comes to essential, optimal treatment for Hepatitis C and TB.
By 2020, the vast majority of people living with HIV (87%) will be in high- and middle-income countries. A sustainable response to HIV, Hep C and TB will not be possible without tackling the intellectual property (IP) barriers preventing access to medcines.
Argentina has around 126,000 people living with HIV, of which fewer than 70,000 people are on antiretroviral therapy. The high prices of drugs limits the number of people who can get treatment.
With a small population and low prevalence rates, universal access for HIV, Hepatitis C and TB should be easily achievable...
Tackling unmerited patents and over-pricing to support the government’s goal of universal access. There were 19,000 people living with HIV...
In Brazil there are 780,000 people living with HIV, of which 405,000 are on HIV treatment. All patients get treatment free from the public health system which, as a result of the high price of drugs, is under severe strain.
Turning commitments and targets into reality in El Salvador. El Salvador has a HIV prevalence rate of 0.6%. An estimated...
Working towards a sustainable approach for access to medicines in Georgia, particularly in light of the country preparing for Global...
Campaigning for optimal and increased treatment coverage in Guatemala to improve quality of life, decrease new infections and reduce stigma...
Addressing gaps in data as a first step to securing essential medicines for people living HIV, Hepatitis C and TB....
Over 2 million people are living with HIV in India. 1.7 million are registered in the antiretroviral program, and over 600,00 are on treatment.
Ensuring Kazakhstan’s national response to HIV, Hep C and TB is ‘fit-for-purpose’ and affordable. An estimated 27,000 people are living...
Building on the country’s new laws and guidelines to achieve everyone’s right to essential medicines – and at a fair...
Moldova’s government has committed to universal access to health services following the withdrawal of Global Fund support. Over-priced medicines are...
Working towards an improved patent system, to achieve more affordable medicines in Morocco. We’re working to increase access to affordable...
Working to close the significant treatment gap and see more people on optimal treatment in Russia. An estimated one million...
An estimated half a million people live with HIV in Thailand. Of these people almost 300,000 are on HIV treatment under a national health insurance scheme paid for by the government.
Ukraine has over 250,000 people living with HIV, of which around 61,000 people are on antiretroviral therapy. According to the National Treatment Program over 118,000 people will be receiving treatment by 2018.
Patents on key HIV, Hepatitis C and TB drugs are preventing universal access in Vietnam. Our partner, VNP+, is advocating...